» Articles » PMID: 37127846

Interlink Between the Gut Microbiota and Inflammation in the Context of Oxidative Stress in Alzheimer's Disease Progression

Overview
Journal Gut Microbes
Date 2023 May 1
PMID 37127846
Authors
Affiliations
Soon will be listed here.
Abstract

The microbiota-gut-brain axis is an important pathway of communication and may dynamically contribute to Alzheimer's disease (AD) pathogenesis. Pathological commensal gut microbiota alterations, termed as dysbiosis, can influence intestinal permeability and break the blood-brain barrier which may trigger AD pathogenesis via redox signaling, neuronal, immune, and metabolic pathways. Dysbiosis increases the oxidative stress. Oxidants affect the innate immune system through recognizing microbial-derived pathogens by Toll-like receptors and initiating the inflammatory process. Most of the gut microbiome research work highlights the relationship between the gut microbiota and AD, but the contributory connection between precise bacteria and brain dysfunction in AD pathology cannot be fully demonstrated. Here, we summarize the current information of the fundamental connections between oxidative stress, inflammation, and gut dysbiosis in AD. This review emphasizes on the involvement of gut microbiota in the regulation of oxidative stress, inflammation, immune responses including central and peripheral cross-talk. It provides insights for novel preventative and therapeutic approaches in AD.

Citing Articles

Gut microbiota may affect Alzheimer's disease through synaptic function mediated by CAMs pathway: A study combining Mendelian randomization and bioinformatics.

Liu J, Tan C, Luo L, Yin X J Alzheimers Dis Rep. 2025; 9:25424823241310719.

PMID: 40034528 PMC: 11864269. DOI: 10.1177/25424823241310719.


A study to determine the effect of nano-selenium and thymoquinone on the Nrf2 gene expression in Alzheimer's disease.

Ellakwa D, Rashed L, Ali O, El-Sabbagh N Future Sci OA. 2025; 11(1):2458434.

PMID: 39887156 PMC: 11792829. DOI: 10.1080/20565623.2025.2458434.


Radiation-Induced Brain Injury: Mechanistic Insights and the Promise of Gut-Brain Axis Therapies.

Li M, Tong F, Wu B, Dong X Brain Sci. 2025; 14(12.

PMID: 39766494 PMC: 11674909. DOI: 10.3390/brainsci14121295.


Neuroimaging techniques, gene therapy, and gut microbiota: frontier advances and integrated applications in Alzheimer's Disease research.

Wang H, Shi C, Jiang L, Liu X, Tang R, Tang M Front Aging Neurosci. 2024; 16:1485657.

PMID: 39691161 PMC: 11649678. DOI: 10.3389/fnagi.2024.1485657.


Implications of the Gut Microbiome in Alzheimer's Disease: A Narrative Review.

Mroke P, Goit R, Rizwan M, Tariq S, Rizwan A, Umer M Cureus. 2024; 16(11):e73681.

PMID: 39677207 PMC: 11646158. DOI: 10.7759/cureus.73681.


References
1.
Nagpal R, Neth B, Wang S, Craft S, Yadav H . Modified Mediterranean-ketogenic diet modulates gut microbiome and short-chain fatty acids in association with Alzheimer's disease markers in subjects with mild cognitive impairment. EBioMedicine. 2019; 47:529-542. PMC: 6796564. DOI: 10.1016/j.ebiom.2019.08.032. View

2.
Jones R, Desai C, Darby T, Luo L, Wolfarth A, Scharer C . Lactobacilli Modulate Epithelial Cytoprotection through the Nrf2 Pathway. Cell Rep. 2015; 12(8):1217-25. PMC: 4640184. DOI: 10.1016/j.celrep.2015.07.042. View

3.
Vogt N, Kerby R, Dill-McFarland K, Harding S, Merluzzi A, Johnson S . Gut microbiome alterations in Alzheimer's disease. Sci Rep. 2017; 7(1):13537. PMC: 5648830. DOI: 10.1038/s41598-017-13601-y. View

4.
Dumitrescu L, Popescu-Olaru I, Cozma L, Tulba D, Hinescu M, Ceafalan L . Oxidative Stress and the Microbiota-Gut-Brain Axis. Oxid Med Cell Longev. 2019; 2018:2406594. PMC: 6304899. DOI: 10.1155/2018/2406594. View

5.
Ghosh S, Whitley C, Haribabu B, Jala V . Regulation of Intestinal Barrier Function by Microbial Metabolites. Cell Mol Gastroenterol Hepatol. 2021; 11(5):1463-1482. PMC: 8025057. DOI: 10.1016/j.jcmgh.2021.02.007. View